Similar response to adalimumab in patients with active Crohn's disease either naive to biologic agents or with prior loss of response or intolerance to infliximab.

@article{Triantafillidis2010SimilarRT,
  title={Similar response to adalimumab in patients with active Crohn's disease either naive to biologic agents or with prior loss of response or intolerance to infliximab.},
  author={John K. Triantafillidis and George Mantzaris and John A. Karagiannis and E Papavasilliou and G V Papatheodoridis and John Fouskas and Georgios Malgarinos and Aristophanis Gikas and Konstantinos Papamichael and Nicoletta Mathou and E Symboulakis and Demetrios G. Karamanolis},
  journal={Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi},
  year={2010},
  volume={114 1},
  pages={85-90}
}
UNLABELLED The aim of this study was to investigate the efficacy of adalimumab, in patients with moderately active Crohn's disease (CD), either naive to biologic agents or with prior loss of response or intolerance to infliximab. MATERIAL AND METHOD A total number of 30 patients with moderately active CD (14 men, 16 women, aged 38.5 +/- 14.4 yr) either naive to biologic agent treatment (19 pts (65%)) or with loss of response or intolerance to infliximab (11 pts (35%)), were enrolled to 4-wk… CONTINUE READING

Similar Papers

Loading similar papers…